Anthony Meager

Anthony Meager's AcademicInfluence.com Rankings

Anthony Meager

Philosophy

#9831

World Rank

#13445

Historical Rank

Logic

#6790

World Rank

#8339

Historical Rank

philosophy Degrees

Anthony Meager

Biology

#13524

World Rank

#17073

Historical Rank

Immunology

#938

World Rank

#962

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Anthony Meager's Degrees

Doctorate Medicine Stanford University

Why Is Anthony Meager Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anthony Meager's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines (2010) (551)
Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. (1992) (459)
Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1 (2006) (360)
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. (1991) (333)
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS (1987) (330)
TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES (1988) (283)
ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE (1988) (274)
Biological activity of interleukins-28 and -29: comparison with type I interferons. (2005) (234)
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients (1988) (231)
Cytokine regulation of cellular adhesion molecule expression in inflammation. (1999) (227)
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. (1989) (204)
Assays for tumour necrosis factor and related cytokines. (1989) (203)
Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. (2007) (203)
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. (1988) (197)
TUMOUR NECROSIS FACTOR IN BRONCHOPULMONARY SECRETIONS OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME (1989) (196)
Cytokines in proliferative vitreoretinopathy (1991) (191)
Anti‐cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon‐alpha, interferon‐omega and interleukin‐12 in patients with thymoma and/or myasthenia gravis (2003) (161)
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity (1989) (149)
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. (1989) (147)
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. (2008) (143)
Cytokines in skin lesions of psoriasis. (1990) (137)
Biological assays for interferons. (2002) (137)
Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. (1990) (136)
High levels of interferon alpha in the sera of children with dengue virus infection. (1993) (133)
TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. (1993) (129)
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions (2012) (127)
Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. (2012) (125)
Aire-Deficient C57BL/6 Mice Mimicking the Common Human 13-Base Pair Deletion Mutation Present with Only a Mild Autoimmune Phenotype1 (2009) (121)
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS‐1) (2007) (119)
In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. (1989) (118)
Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: Clinical and pathogenetic implications (2011) (115)
Effect of cyclo‐oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide‐induced neutrophil infiltration in mouse lung (1996) (109)
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. (1990) (107)
INTERFERON INDUCTION AND INCREASED NATURAL KILLER-CELL ACTIVITY IN INFLUENZA INFECTIONS IN MAN (1981) (100)
Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes (2008) (100)
Clonal analysis of functionally distinct human CD4+ T cell subsets (1988) (97)
Immunohistochemical Localization of Interferons in Human Placental Tissues in Normal, Ectopic, and Molar Pregnancy (1990) (94)
Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection (1990) (93)
Cutting Edge: TRANK, a Novel Cytokine That Activates NF-κB and c-Jun N-Terminal Kinase (1998) (88)
Spontaneous neutralising antibodies to interferon-a and interleukin-12 in thymoma-associated autoimmune disease (1997) (85)
Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor‐alpha production in Pneumocystis carinii pneumonia (1990) (83)
Cytokines in sera from insulin‐dependent diabetic patients at diagnosis (1991) (81)
Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. (2000) (79)
Cytokine inter-relationships and their association with disease activity in arthritis. (1992) (75)
The role of tumour necrosis factor‐alpha and IL‐1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis (1994) (73)
Assays for transforming growth factor β (1991) (72)
Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. (1995) (72)
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus (1981) (72)
Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV‐infected individuals (1991) (70)
Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (2008) (70)
Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. (2003) (69)
Autoimmunizing Mechanisms in Thymoma and Thymus * (2008) (68)
Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis (2003) (67)
Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection (1990) (63)
Anti-Cytokine Autoantibodies Preceding Onset of Autoimmune Polyendocrine Syndrome Type I Features in Early Childhood (2013) (59)
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum (1990) (58)
Passive immunization against tumour necrosis factor‐alpha (TNF‐α) and IL‐lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats (1992) (58)
Phenotypic and functional analysis of human CD3- decidual leucocyte clones. (1990) (55)
Human NK cells constitutively express membrane TNF‐α (mTNFα) and present mTNFα‐dependent cytotoxic activity (1999) (55)
Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). (1987) (54)
Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. (1996) (54)
Measurement of cytokines by bioassays: theory and application. (2006) (54)
Localization of α-interferon in the human feto-placental unit (1988) (53)
Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. (1989) (51)
Neutralizing antibodies to granulocyte–macrophage colony‐stimulating factor, interleukin‐1α and interferon‐α but not other cytokines in human immunoglobulin preparations (2000) (51)
Application of an immortalized human endothelial cell line to the leucocyte:endothelial adherence assay. (1993) (51)
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. (1997) (50)
Anti‐cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice (2013) (49)
The interferons : characterization and application (2006) (48)
TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. (1998) (47)
Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. (1992) (45)
Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen Transcripts in Their Tumors (2014) (44)
DETECTION OF PYROGEN BY CYTOKINE RELEASE (1988) (43)
Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. (1990) (42)
Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. (2001) (42)
AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I (2008) (41)
Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor. (1990) (41)
Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. (1986) (40)
Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity. (1999) (39)
Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. (1986) (39)
Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes. (1988) (38)
Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. (1993) (36)
An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta products. (2011) (36)
Effects of macrophage‐colony stimulating factor on human monocytes: Induction of expression of urokinase‐type plasminogen activator, but not of secreted prostaglandin E2, interleukin‐6, interleukin‐1, or tumor necrosis factor‐a (1993) (36)
Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. (1991) (35)
Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. (2008) (35)
Involvement of a gene on chromosome 9 in human fibroblast Interferon production (1979) (35)
A cytotoxicity assay for tumour necrosis using a human rhabdomyosarcoma cell line (1991) (34)
Detection of hybridomas secreting monoclonal antibodies to human gamma interferon using a rapid screening technique and specificity of certain monoclonal antibodies to gamma interferon. (1984) (32)
Transforming growth factor‐β induced by live or ultraviolet‐inactivated equid herpes virus type‐1 mediates immunosuppression in the horse (1997) (32)
Characterization of interferon messenger RNA from human lymphoblastoid cells. (1979) (32)
Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients (2000) (32)
Hepatic interferon‐α gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection (1991) (32)
Gene Therapy Technologies, Applications and Regulations (1999) (31)
Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. (1992) (30)
IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes. (1986) (30)
Suppression of lymphokine‐activated killer (LAK) cell induction mediated by interleukin‐4 and transforming growth factor‐β1: effect of addition of exogenous tumour necrosis factor‐alpha and interferon‐gamma, and measurement of their endogenous production (1990) (29)
Enhancement of interferon mRNA levels in butyric acid‐treated namalwa cells (1980) (29)
Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. (1996) (29)
Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. (1989) (28)
Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model (2007) (28)
Virus RNA and protein synthesis in cells infected with different strains of Newcastle disease virus. (1971) (28)
Factors Involved in the Production of Interferon by Inactivated Newcastle Disease Virus (1972) (28)
Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. (2005) (28)
Hypothetical review: thymic aberrations and type‐I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes (2008) (27)
T cell activation in vivo by dengue virus infection. (1995) (27)
Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid. (1993) (26)
Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy (1989) (26)
Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-γ responses of healthy CD4+ T cells (2003) (25)
Somatic cell genetics of human interferon production in human-rodent cell hybrids. (1979) (24)
Production of Interferon by Ultraviolet Radiation Inactivated Newcastle Disease Virus (1972) (23)
Influenza virus-specific T cells lead to early interferon gamma in lungs of infected hosts: development of a sensitive radioimmunoassay. (1989) (23)
Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA. (2009) (23)
The molecular biology of cytokines (1998) (23)
Reduction of tumor necrosis factor α and interleukin-1β levels in human synovial tissue by interleukin-4 and glucocorticoid (1992) (22)
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus. (1990) (22)
What mediates the immunopathological component of the immune response to Mycobacterium tuberculosis? Can it be switched off? (1990) (22)
Interferons Alpha, Beta, and Omega (1998) (21)
A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha. (1984) (21)
Expanded TCR Vβ subsets of CD8+ T-cells in late-onset myasthenia gravis: Novel parallels with thymoma patients (2009) (20)
The preparation of interferon gamma-producing T-cell hybridomas from jacalin-stimulated T lymphocytes and the SH9 T-cell line. (1984) (20)
Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis a (1998) (20)
Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. (1986) (20)
Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells. (1987) (20)
Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. (2007) (19)
Tumor necrosis factor mediates the protective effect of Freund's adjuvant against autoimmune diabetes in BB rats. (1995) (19)
The Effect of HLA and Insulin‐Dependent Diabetes Mellitus on the Secretion Levels of Tumour Necrosis Factors Alpha and Beta and Gamma Interferon (1990) (19)
Assays for antiviral activity. (2004) (19)
Measuring Autoantibodies against IL‐17F and IL‐22 in Autoimmune Polyendocrine Syndrome Type I by Radioligand Binding Assay Using Fusion Proteins (2011) (19)
Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations. (2000) (18)
TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells. (1994) (18)
Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups (2012) (18)
Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF). (1995) (18)
Expression of intercellular adhesion molecule-1 (ICAM-1) on human thyroid cell lines correlated with their binding of lymphoblasts (1990) (18)
Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons? (2010) (17)
EC (European Communities) Workshop on Human Somatic Gene Therapy September 23-24, 1993, Sponsored by the Commission of the European Communities Directorate--General XII for Science, Research and Development (1994) (17)
A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applications. (1987) (17)
Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients. (2000) (16)
IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma. (1991) (16)
Assays for transforming growth factor beta. (1991) (16)
Tumour necrosis factor production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis. (1992) (15)
Bioimmunoassays for proinflammatory cytokines involving cytokine-induced cellular adhesion molecule expression in human glioblastoma cell lines. (1996) (15)
Production and screening of cell hybrids producing a monoclonal antibody to human interferon-alpha. (1981) (15)
Detection of anti-cytokine antibodies and their clinical relevance (2014) (14)
Mechanism of suppression of normal hemopoietic activity by lymphokine-activated killer cells and their products. (1991) (13)
Development of resistance to tumour necrosis factor (TNF alpha) in KYM-1 cells involves both TNF receptors. (1993) (13)
Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assay. (2010) (13)
Studies on the structural basis of the RNA polymerase activity of newcastle disease virus particles. (1973) (13)
Interferon production: variation in yields from human cell lines (1979) (12)
Interferon standardization and designations. (1997) (12)
Natural autoantibodies to interferons. (1997) (12)
Tumour necrosis factor in bronchopulmonary secretion of patients with adult respiratory distress syndrome (1989) (12)
Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gamma. (1985) (11)
A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. (1991) (11)
Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432. (1986) (11)
Interferon production by human-mouse hybrid cells: dominant mouse control of superinduction and priming. (1980) (11)
Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals (1990) (10)
Aire-Deficient C 57 BL / 6 Mice Mimicking the Common Human 13-Base Pair Deletion Mutation Present with Only a Mild Autoimmune Phenotype 1 (2009) (10)
Protein kinase C-dependent phosphorylation is involved in resistance to tumour necrosis factor-alpha-induced cytotoxicity in a human monocytoid cell line. (1993) (10)
The effect of hypertonic salt on interferon and interferon mRNA synthesis in human MG63 cells. (1982) (10)
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples. (2013) (10)
An anti-cytokine bioactivity assay for interferons-α, -β and -ω (1996) (9)
Stimulation of interferon yields from cultured human cells by calcium salts (1978) (9)
Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-alpha subtypes. (1986) (9)
Characterization and partial purification of a novel cytotoxic lymphokine (factor 2) produced by a human B cell line (Karpas 160). (1992) (9)
Human antibodies to insulin in diabetes. (1994) (9)
Localization of alpha-interferon in the human feto-placental unit. (1988) (8)
The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study. (1996) (8)
Viral Inhibitors and Immune Response Mediators: The Interferons (2006) (8)
An Overview of Cytokine Regulation of Inflammation and Immunity (2013) (8)
Raised levels of tumor-necrosis factor alpha (TNFα) in cardiac transplant patients (1993) (8)
Hepatic expression of interferon-α in chronic hepatitis B virus infection (1994) (7)
Antigenic characteristics of glycosylated natural and unglycosylated recombinant human gamma-interferon. (1986) (7)
A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells. (2008) (7)
International collaborative study of the candidate international standards for human tumour necrosis factors alpha (hTNF-α) and beta (hTNF-β) and for murine tumour necrosis factor alpha (mTNF-α) (1994) (7)
Human somatic gene therapy. (1994) (7)
Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b): Application of new reporter gene assay for IFN-α2b potency determinations (2007) (7)
Gene therapy technologies, applications and regulations : from laboratory to clinic (1999) (7)
Spontaneous production of gamma interferon and induced production of beta interferon by human T-lymphoblastoid cell lines (1982) (7)
Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method. (2013) (6)
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines. (1997) (6)
Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substances. (2004) (6)
Agonistic and Antagonistic Antibodies as a Tool to Study the Functional Role of Human Tumor Necrosis Factor Receptors (1993) (6)
IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF. (1996) (6)
Expression of the human interferon-β gene cloned in phage M13 mp7 (1983) (6)
A tumour necrosis factor-alpha (TNF-α) sensitive adherent KYM-1D4 derived cell line : Use in TNF-α cytotoxicity assays in the presence of actinomycin D (1999) (5)
Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. (1991) (5)
Ricin-resistant human T-cell hybridomas producing interferon gamma. (1985) (5)
Production ofinterferon-gamma andtumour necrosis factor-alpha by humanT-cell clones expressing different formsoftheybreceptor (1990) (5)
Tumor necrosis factor (TNF)-induced protein phosphorylation in a human rhabdomyosarcoma cell line is mediated by 60-kD TNF receptors (TR60). (1994) (4)
An anti-cytokine bioactivity assay for interferons-alpha, -beta and -omega. (1996) (4)
Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1). (2014) (4)
Cell‐Based Assays for the Detection of Neutralizing Antibodies to Interferon Beta (IFN‐β) and Tumor Necrosis Factor Alpha (TNF‐α) Inhibitors (2011) (3)
Aicardi–Goutières syndrome presenting with haematemesis in infancy (2009) (3)
Comment on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections” (2021) (3)
Evaluation of activity, aggregation and NAB testing with generic interferon beta products: implications for treating multiple sclerosis (2008) (2)
Modulation of anti-tumor cytotoxicity of cultured mast cells by metabolic inhibitors. (1992) (2)
Interferon gamma produced by mitogen‐activated T lymphocytes does not directly mediate lymphoproliferation (1985) (2)
Assays for cytotoxicity. (2004) (2)
Fourth International Congress on Tumour Necrosis Factor and Related Cytokines. Meeting at Koningshof, Veldhoven, The Netherlands 2-6 May 1992. (1992) (2)
The interferons: Past, present and future (2009) (2)
GENETIC CONTROL OF INTERFERON FORMATION (1980) (2)
INTERFERON-α PRIMES EARLY PROLIFERATIVE RESPONSE OF BONE MARROW CELLS IN VIVO (1998) (2)
Improvement of potential therapeutic value of tumor necrosis-α (TNF-α) by charge modulation in the tip region (2005) (2)
Production of TNF α and IL-1β in association with clearance of hepatitis B virus in interferon treated carriers (1989) (1)
Development of interferon-specific monoclonal antibody for in vitro interferon assays. (1986) (1)
Gene Transfer Vectors for Clinical Applications (2007) (1)
Biological standardization of cytokines. (1988) (1)
International collaborative study of the candidate international standards for human tumour necrosis factors alpha (hTNF-alpha) and beta (hTNF-beta) and for murine tumour necrosis factor alpha (mTNF-alpha). (1994) (1)
The Development of the Regulatory Process in Europe for Biological Medicines: How it Affects Gene Therapy Products (2001) (1)
EC workshop on human somatic gene therapy. Commission of the European Communities Directorate--General XII for Science, Research and Development, 23-24 September 1993. (1994) (1)
Biological Standardization of Interferons and Other Cytokines (2008) (1)
Lymphotoxin and Class II HLA-DR Co-Precipitate? (1989) (1)
Clonal analysis of the relationship between class II MHC-restricted cytolysis and lymphokine secretion in murine L3T4+ T cells. (1991) (1)
Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region. (2005) (1)
Short communication Effect of IFNb and anti-IFNb antibodies on NK cells in multiple sclerosis patients (2000) (1)
Expression of the human interferon-beta gene cloned in phage M13 mp7. (1983) (0)
Immunoassays for human tumour necrosis factors alpha and beta (1988) (0)
TNF-α Signal Transduction Involves Distinct Phosphorylation Events in U937 Histiocytic Cells (1991) (0)
A tumour necrosis factor-alpha (TNF-alpha) sensitive adherent KYM-1D4 derived cell line: use in TNF-alpha cytotoxicity assays in the presence of actinomycin D. (1999) (0)
Synthetic peptides as an analytical tool for studying ligand-acceptor binding (1992) (0)
Tnf alpha mediated cytolysis in human kym 1 cells is mediated by p60 tnf receptors (1991) (0)
Measurement of neutralising antibodies to human interferon-[beta] by quantitative analysis of type 1 interferon inducible 6-16 mRNA (2008) (0)
Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1. (2023) (0)
Haematopoietic Growth Factors in Clinical Applications (1991) (0)
Transcripts in Their Tumors Patients with Thymomas and Autoantigen Clinical and Serologic Parallels to APS-I in (2014) (0)
Quality assurance of biologics and conclusions to be drawn for gene therapy products (1997) (0)
Report on a collaborative study for proposed 1 st WHO reference reagent for human interleukin-29 (IL-29) (2012) (0)
Book reviewInterferom and Nonviral pathogens: Byrne, G.I. and Turco, J. (Eds.), vii + 317 pp. Marcell Dekker, New York 1988. $ 119.50, ISBN 0-824-77973-8 (1989) (0)
Factors involved in the producton of interferon by inactivated Newcastle disease virus. (1972) (0)
Cytokine Interactions and Their Control (1992) (0)
Tumor necrosis factor in tulminant hepatic failure (1990) (0)
Production of human alpha- and beta- interferons by human-rodent hybrids. (1982) (0)
EC workshop on human somatic gene therapy editorial note (1995) (0)
5th International Congress on Tumour Necrosis Factor and Related Cytokines: Scientific Advances and their Medical Applications. (1994) (0)
J. P. Lecocq Conference on gene therapy. 5-7 July 1994 Ecole Superieure de Biotechnologie de Strasbourg, Pole API, Parc d'Innovation, Illkirch, Nr Strasbourg, France. (1995) (0)
Anti-Cytokine Autoantibodies Preceding Onset of Autoimmune Polyendocrine Syndrome Type I Features in Early Childhood (2013) (0)
Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups (2011) (0)
Interferon alpha primes early proliferative response of bone marrow cells in vivo. (1998) (0)
Studies on the replication and functions of Newcastle disease virus ribonucleic acids (1972) (0)
Human Cytokine Standards and Reference Reagents (2000) (0)
Standardization of human IFN gamma in comparison with other interferons. (1986) (0)
Therapeutic efficacy of interferon-beta in a xenograft model of acute myeloid leukaemia (2006) (0)
Mutation Present with Only a Mild Common Human 13-Base Pair Deletion Aire-Deficient C57BL/6 Mice Mimicking the (2013) (0)
The year in immunology 1988, vol. 5: Immunoregulatory cytokines and cell growth: Cruse, J.M. and Lewis, Jr., R.E. (Eds.) Karger, Basel, 1989. £ 90.00, ISBN 8055-4895-8 (1989) (0)
Standardization of Human IL-29 (IFN- l 1): Establishment of a World Health Organization International Reference Reagent for IL-29 (IFN- l 1) Participants of the Collaborative Study (2014) (0)
Interferons and other regulatory cytokines: De Maeyer, E. and De Maeyer-Guignard, J., 448 pp. John Wiley, New York, 1988. £ 62.50, ISBN 0-471-82887-4 (1989) (0)
Originals Reduction of tumor necrosis factor 9 and interleukin-lfl levels in human synovial tissue by interleukin-4 and glucocorticoid (0)
Human cell lines used for interferon production survey ' INFECT . IMMUN (0)
Effect ofcyclo-oxygenase inhibitors andmodulators ofcyclic AMP formation on lipopolysacchari de-induced neutrophil infiltration inmouse lung (1996) (0)
National Institute for Biological Standards and Control. Human cytokine standards and reference reagents. (2000) (0)
The Role of Lymphotoxin in the Pathogenesis of Celiac Disease (1989) (0)
Evidence for a role of IFN γ in control ofListeria monocytogenes in T cell deficient mice (1991) (0)
Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations. (2007) (0)
Stabilisation of cytokine solutions by casein (2001) (0)
Cell Lines and Primary Tissues for In‐Vitro Evaluation of Vaccine Efficacy (2006) (0)
Blockade of cytokine activity by soluble cytokine receptors (2000) (0)
INDUCTION OF IMMUNE INTERFERON FROM HUMAN LYMPHOCYTES BY INFLUENZA-INFECTED STIMULATOR CELLS (1982) (0)

This paper list is powered by the following services:

Anthony Meager's Academic­Influence.com Rankings

Anthony Meager's Degrees

Why Is Anthony Meager Influential?

Anthony Meager's Published Works

Published Works

Anthony Meager's AcademicInfluence.com Rankings